Audience Partners Raises $750K Series A Funding

Cuprum Metals

Revolutionizing Copper Extraction: Cuprum Metals' proprietary technology leverages advanced leaching techniques to unlock previously untapped copper resources with maximum, time-efficient recovery rates and minimal environmental impact. Cuprum’s technology offers major mining companies a more efficient, cost-effective and eco-friendly alternative to traditional leaching practices and current competing technologies. Testing Results: Total Time to Leach: 30 Minutes Yield: +92% Cu recovery at room temperature 98% Cu recovery at 55 degrees Celsius *No Toxic Chemicals used in the Leach Mining Companies and Investors: To learn more, please contact: Roger.pettman@cuprummetals.com

HyperLight

The information age relies on billions of devices converting signals between electricity and light waves. These integrated light circuits are the backbone of telecommunication infrastructures, data centers, sensors, and even secure quantum communications. Our devices set new benchmarks for performance, including extraordinary speed and efficiency, that will force industries to rethink and reimagine their current standards.

Gradial

Enterprise content supply chains are broken. Fragmented tools, messy data, and endless delays leave marketing teams struggling to deliver consistent omni-channel experiences. It’s time for a change that brings speed, clarity, and scalability to your operations. Gradial breaks the cycle by cutting delays, simplifying operations, and empowering your team to focus on what matters most—your brand and customers.

Cargofy

Cargofy is an AI-powered logistics tool that matches trucks with loads across multiple load boards. Our platform automates truck-load matching, trip coordination, and delivery tracking. This service helps trucking companies avoid empty miles, saving both time and fuel. Founded by Stakh Vozniak, Alex Kovalchuk, and Dimitri Alexiou, Cargofy is headquartered in Cedar Rapids, Iowa, and operates under the Forward Group brand.

Gero

We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once. You can find our publications here: https://gero.ai/publications